Versant Venture Capital VI, L.P. insider trades: LENZ Therapeutics (LENZ) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Versant Venture Capital VI, L.P. reports to the SEC
and 8 more companies
Open-market buys and sales
70 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | LENZ | ↓ Sell | 132,944 | $46.01 | $6.1M | Direct | Oct 2, 2025 (2d) |
| Sep 30, 2025 | LENZ | ↓ Sell | 92,030 | $46.01 | $4.2M | Indirect | Oct 2, 2025 (2d) |
| Sep 19, 2025 | LVTX | ↓ Sell | 2,370,533 | $1.40 | $3.3M | Direct | Sep 23, 2025 (4d) |
| Sep 19, 2025 | LVTX | ↓ Sell | 532,870 | $1.40 | $747K | Indirect | Sep 23, 2025 (4d) |
| Sep 18, 2025 | LENZ | ↓ Sell | 90,654 | $42.23 | $3.8M | Direct | Sep 22, 2025 (4d) |
| Sep 18, 2025 | LENZ | ↓ Sell | 44,650 | $42.23 | $1.9M | Indirect | Sep 22, 2025 (4d) |
| Sep 18, 2025 | LVTX | ↓ Sell | 1,036,624 | $1.49 | $1.5M | Direct | Sep 18, 2025 (0d) |
| Sep 18, 2025 | LVTX | ↓ Sell | 647,810 | $1.49 | $962K | Indirect | Sep 18, 2025 (0d) |
| Aug 26, 2025 | LENZ | ↓ Sell | 126,023 | $39.47 | $5.0M | Direct | Aug 26, 2025 (0d) |
| Aug 26, 2025 | LENZ | ↓ Sell | 62,071 | $39.47 | $2.4M | Indirect | Aug 26, 2025 (0d) |
| Aug 18, 2025 | LENZ | ↓ Sell | 175,679 | $39.34 | $6.9M | Direct | Aug 19, 2025 (1d) |
| Aug 18, 2025 | LENZ | ↓ Sell | 85,034 | $39.33 | $3.3M | Indirect | Aug 19, 2025 (1d) |
| Jul 10, 2025 | LENZ | ↓ Sell | 191,376 | $34.00 | $6.5M | Direct | Jul 14, 2025 (4d) |
| Jun 27, 2025 | LENZ | ↓ Sell | 200,000 | $30.46 | $6.1M | Direct | Jul 1, 2025 (4d) |
| Jun 20, 2025 | LENZ | ↓ Sell | 200,877 | $30.15 | $6.1M | Indirect | Jun 20, 2025 (0d) |
| Jun 20, 2025 | LENZ | ↓ Sell | 133,924 | $30.25 | $4.1M | Direct | Jun 20, 2025 (0d) |
| Jun 10, 2025 | LENZ | ↓ Sell | 350,000 | $29.00 | $10.2M | Indirect | Jun 12, 2025 (2d) |
| Oct 29, 2024 | GLUE | ↓ Sell | 157,895 | $9.44 | $1.5M | Indirect | Oct 30, 2024 (1d) |
| Sep 20, 2024 | GLUE | ↓ Sell | 1,132,566 | $6.53 | $7.4M | Direct | Sep 24, 2024 (4d) |
| Sep 13, 2024 | GLUE | ↓ Sell | 567,213 | $6.00 | $3.4M | Direct | Sep 13, 2024 (0d) |
| Aug 28, 2024 | BDTX | ↓ Sell | 221,600 | $6.32 | $1.4M | Direct | Aug 30, 2024 (2d) |
| Aug 12, 2024 | TPST | ↓ Sell | 787,999 | $1.23 | $967K | Direct | Aug 12, 2024 (0d) |
| Aug 9, 2022 | IPSC | ↓ Sell | 550,000 | $13.03 | $7.2M | Direct | Aug 11, 2022 (2d) |
| Jun 3, 2022 | RPTX | ↓ Sell | 750,000 | $12.25 | $9.2M | Indirect | Jun 7, 2022 (4d) |
| Oct 18, 2021 | OYST | ↓ Sell | 550,000 | $14.84 | $8.2M | Indirect | Oct 20, 2021 (2d) |
| Jun 29, 2021 | GRPH | ↑ Buy | 180,000 | $17.00 | $3.1M | Indirect | Jul 1, 2021 (2d) |
| Jun 28, 2021 | GLUE | ↑ Buy | 157,895 | $19.00 | $3.0M | By Versant Vantage I, L.P. | Jun 30, 2021 (2d) |
| Jun 22, 2021 | IPSC | ↑ Buy | 100,000 | $20.00 | $2.0M | Indirect | Jun 23, 2021 (1d) |
| Nov 30, 2020 | BDTX | ↓ Sell | 10,393 | $33.15 | $345K | Indirect | Dec 1, 2020 (1d) |
| Nov 19, 2020 | BDTX | ↓ Sell | 114,854 | $33.01 | $3.8M | Direct | Nov 23, 2020 (4d) |
| Nov 19, 2020 | BDTX | ↓ Sell | 15,163 | $33.01 | $501K | Indirect | Nov 23, 2020 (4d) |
| Nov 18, 2020 | BDTX | ↓ Sell | 4,178 | $33.05 | $138K | Direct | Nov 19, 2020 (1d) |
| Nov 18, 2020 | BDTX | ↓ Sell | 552 | $33.05 | $18K | Indirect | Nov 19, 2020 (1d) |
| Nov 16, 2020 | BDTX | ↓ Sell | 4,152 | $33.74 | $140K | Direct | Nov 17, 2020 (1d) |
| Nov 16, 2020 | BDTX | ↓ Sell | 548 | $33.74 | $18K | Indirect | Nov 17, 2020 (1d) |
| Nov 12, 2020 | BDTX | ↓ Sell | 13,779 | $34.15 | $471K | Direct | Nov 13, 2020 (1d) |
| Nov 12, 2020 | BDTX | ↓ Sell | 1,819 | $34.15 | $62K | Indirect | Nov 13, 2020 (1d) |
| Nov 11, 2020 | BDTX | ↓ Sell | 34,967 | $34.11 | $1.2M | Direct | Nov 12, 2020 (1d) |
| Nov 11, 2020 | BDTX | ↓ Sell | 4,616 | $34.11 | $157K | Indirect | Nov 12, 2020 (1d) |
| Nov 9, 2020 | BDTX | ↓ Sell | 8,303 | $33.08 | $275K | Direct | Nov 10, 2020 (1d) |
| Nov 9, 2020 | BDTX | ↓ Sell | 1,097 | $33.08 | $36K | Indirect | Nov 10, 2020 (1d) |
| Nov 5, 2020 | BDTX | ↓ Sell | 10,024 | $33.14 | $332K | Direct | Nov 6, 2020 (1d) |
| Nov 5, 2020 | BDTX | ↓ Sell | 1,324 | $33.14 | $44K | Indirect | Nov 6, 2020 (1d) |
| Oct 27, 2020 | BDTX | ↓ Sell | 7,865 | $33.28 | $262K | Direct | Oct 28, 2020 (1d) |
| Oct 27, 2020 | BDTX | ↓ Sell | 1,038 | $33.28 | $35K | Indirect | Oct 28, 2020 (1d) |
| Oct 20, 2020 | ALGS | ↑ Buy | 200,000 | $15.00 | $3.0M | Indirect | Oct 20, 2020 (0d) |
| Oct 19, 2020 | BDTX | ↓ Sell | 13,909 | $33.44 | $465K | Direct | Oct 20, 2020 (1d) |
| Oct 19, 2020 | BDTX | ↓ Sell | 1,837 | $33.44 | $61K | Indirect | Oct 20, 2020 (1d) |
| Oct 14, 2020 | BDTX | ↓ Sell | 15,229 | $33.30 | $507K | Direct | Oct 15, 2020 (1d) |
| Oct 14, 2020 | BDTX | ↓ Sell | 2,011 | $33.30 | $67K | Indirect | Oct 15, 2020 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other LENZ insiders
Open-market trades in the last 12 months
About Versant Venture Capital VI, L.P.'s insider trades
Versant Venture Capital VI, L.P. is an insider at LENZ Therapeutics (LENZ). Since Jun 24, 2019, it has reported 11 open-market purchases worth $52.9M and 59 sales worth $139.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (29 filings), conversions (11 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LENZ insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.